|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | The Cyclin-dependent kinase inhibitor CYC202(R-roscovitine) inhibits retinoblastoma protein phosphorylation,causes loss of CyclinD1,and activates the mitogen activated protein kinase pathway显示文摘 | Whittaker SR Walton MI Garrett MD | 2004 | Cancer Res2004，64，1： | 1 |
| 2 | Identification of skeletal muscle precursor cells in vivo by use of MyoD1 and myogenin probes显示文摘 | Grounds MD Garrett KL Lai MC | 1992 | Cell Tissue Res1992，267，1： | 1 |
| 3 | Targeting the PI3K-AKT-mTOR pathway:progress,pitfalls,and promises显示文摘 | Yap TA Garrett MD Walton MI | | 0，，： | 1 |
| 4 | Evidence for cancer stem cells contributing to the pathogenesis of ovarian cancer 显示文摘 | Curley MD Garrett LA Schorge JO | 2011 | Front Biosei2011，16，： | 1 |
| 5 | CDK inhibition and cancer therapy显示文摘 | Garrett MD and Fattaey A | 1999 | Current Opinion in Genetics & Development1999，9，1： | 1 |
| 6 | Targeting the PI3K-AKTmTORpathway:progress,pitfalls,and promises显示文摘 | Yap TA Garrett MD Walton MI | | 0，，04： | 1 |
| 7 | Evidence for lateral gene transfer between Archaea and bacteria from genome sequence of Thermotoga maritime 显示文摘 | Nelson KE Clayton RA Gill SR Gwinn ML Dodson RJ Haft DH Hickey EK Peterson JD Nelson WC Ketchum KA McDonald L Utterback TR Malek JA Linher KD Garrett MM Stewart AM Cotton MD Pratt MS Phillips CA Richardson D Heidelberg J Sutton GG Fleischmann RD Eisen JA White O Salzberg SL Smith HO Craig Venter J Fraser CM | 1999 | Nature1999，399，： | 1 |
| 8 | Targeting the PI3K - AKT - mTOR pathway: progress, pitfalls, and promises 显示文摘 | Yap TA Garrett MD Walton MI | 2008 | Curr Opin Pharmaeol2008，8，： | 1 |
| 9 | New functional activites for the p21 family of CDK inhibitors显示文摘 | LaBaer J Garrett MD Stevenson LF | 1997 | Genes Dev1997，11，7： | 1 |
| 10 | Targeting the cell division cycle in cancer: CDK and cell cycle checkpoint kinase in- hibitors显示文摘 | Collins I Garrett MD | 2005 | Curr Opin Pharmacol2005，5，4： | 1 |
| 11 | CDK Inhibition and Cancer Therapy显示文摘 | Fattaey A | 1999 | Curr Opin Genet Dev(England)1999，9，1： | 1 |
| 12 | Neutrophils infiltrating the endometrium express vascular endothelial growth factor: potential role in endometrial angiogenesis显示文摘 | Mueller MD Lebovic D1 Garrett E | 2000 | Fertil Steril2000，74，1： | 1 |
| 13 | New functional activities for the P21 family of CDK inhibitors显示文摘 | LaBaer J Garrett MD Stevenson LF | 1997 | Genes Dew1997，11，7： | 1 |
| 14 | Targeting the PI3K-AKT-mTOR pathway:progress,pitfal s,and promises显示文摘 | Yap TA Garrett MD Walton MI | | 0，，04： | 1 |
| 15 | Neutrophils infiltrating the endometrium express vascular endothelial growth factor potential role in endometrial angiogenesis显示文摘 | Lebovic DI Garrett E | 2000 | Fertil Stefil2000，74，1： | 1 |
| 16 | The transcription of MyoD1 and myogenin genes in thymic cells in vivo显示文摘 | Grounds MD Garrett KL Beilharz MW | 1992 | Exp Cell Res1992，198，2： | 1 |
| 17 | Evidence for cancer stem cells contributing to the pathogenesis of ovarian cancer 显示文摘 | Curley MD Garrett LA Schorge JO | 2011 | Front Biosci(Landmark Ed)2011，16，： | 1 |
| 18 | KRAS Mutation Correlates With Accelerated Metastatic Progression in Patients With Colorectal Liver Metastases显示文摘 | Garrett M. Nash MD Mark Gimbel MD Jinru Shia MD Daniel R. Nathanson MD MacKevin I. Ndubuisi PhD Zhao-Shi Zeng MD Nancy Kemeny MD Philip B. Paty MD | 2010 | Annals of Surgical Oncology2010，，2： | 1 |
| 19 | The Cyclin-dependent kinase inhibitor CYC202 ( R-roscovitine ) inhibits retinoblastoma pro- tein phosphorylation, causes loss of Cyclin D1, and activates the mito- gen-activated protein kinase pat hway 显示文摘 | Whittaker SR Walton MI Garrett MD | 2004 | Cancer Res2004，64，1： | 1 |
| 20 | Targeting the PI3K- AKT-mTOR pathway: progress, pitfalls, and promises 显示文摘 | Yap TA Garrett MD Walton MI | 2008 | Current Opinion in Pharmacology2008，8，4： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员